Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PROCESS LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 POTERS FIVE FORCES
5 ASIA PACIFIC MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN R&D FOR DISCOVERY AND DEVELOPMENT OF NOVEL DRUG MOLECULES
6.1.2 RISE IN CHRONIC DISEASES
6.1.3 INITIATIVES FOR RESEARCH ON RARE DISEASES AND ORPHAN DRUGS
6.1.4 GROWTH IN BIOLOGICS
6.1.5 COLLABORATIONS AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRIES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF FORMULATED DRUG
6.2.2 TECHNICAL RISKS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.2.3 BIOETHICAL ISSUES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN BIOCHEMICAL, TRANSLATIONAL, AND MOLECULAR STUDIES
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 USE OF ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.4 CHALLENGES
6.4.1 BIOLOGICS NEED SPECIALIST TESTING SERVICES
6.4.2 STRINGENT REGULATIONS
7 IMPACT OF COVID-19 ON ASIA PACIFIC MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS BY MANUFACTURERS
7.5 CONCLUSION
8 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS
8.1 OVERVIEW
8.2 TARGET SELECTION
8.3 TARGET VALIDATION
8.4 HIT-TO-LEAD IDENTIFICATION
8.5 LEAD OPTIMIZATION
8.6 CANDIDATE VALIDATION
9 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN
9.1 OVERVIEW
9.2 FRAGMENT-BASED VARIATION
9.3 STRUCTURE BASED DRUG DESIGN
9.4 DIVERSITY ORIENTED SYNTHESIS
9.5 CHEMOGENOMICS
9.6 NATURAL PRODUCTS
9.7 OTHERS
10 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 SMALL MOLECULES
10.3 BIOLOGICS
11 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 NEUROLOGY
11.4 INFECTIOUS AND IMMUNE SYSTEM DISEASES
11.5 CARDIOVASCULAR DISEASES
11.6 DIGESTIVE SYSTEM DISEASES
11.7 OTHERS
12 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER
12.1 OVERVIEW
12.2 CONTRACT RESEARCH ORGANIZATION
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 ACADEMIC AND RESEARCH INSTITUTES
12.5 OTHERS
13 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 PHILIPPINES
13.1.9 MALAYSIA
13.1.10 INDONESIA
13.1.11 VIETNAM
13.1.12 REST OF ASIA-PACIFIC
14 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 EUROFINS SCIENTIFIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 LABCORP DRUG DEVELOPMENT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 SERVICE PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CHARLES RIVER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 SERVICE PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 WUXI APPTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SERVICE PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 EVOTEC SE
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 SERVICE PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 PIRAMAL PHARMA SOLUTIONS
16.6.1 COMPANY SNAPSHOT
16.6.2 SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 THERMO FISHER SCIENTIFIC INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.7.4.1 ACQUISITION
16.8 AURIGENE PHARMACEUTICAL SERVICES (A SUBSIDIARY OF DR. REDDY'S LABORATORIES)
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 SERVICE PORTFOLIO
16.8.4 RECENT DEVELOPMENT
16.9 AURELIA BIOSCIENCES
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 BIOBLOCKS INC
16.10.1 COMPANY SNAPSHOT
16.10.2 SERVICE PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 CERTARA INC
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 SERVICE PORTFOLIO
16.11.4 RECENT DEVELOPMENTS
16.12 DOMAINEX
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 DRUG DISCOVERY ALLIANCES
16.13.1 COMPANY SNAPSHOT
16.13.2 SERVICE PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 GENSCRIPT BIOTECH
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 SERVICE PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 JUBILANT BIOSYS
16.15.1 COMPANY SNAPSHOT
16.15.2 SERVICE PORTFOLIO
16.15.3 RECENT DEVELOPMENTS
16.16 NANOSYN
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 NEREID THERAPEUTICS
16.17.1 COMPANY SNAPSHOT
16.17.2 SERVICE PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 PFIZER INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 SERVICE PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 SELVITA
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 SERVICE PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.19.4.1 ACQUISITION
16.2 SPECTRIS PLC
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 SERVICE PORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 SYGNATURE DISCOVERY
16.21.1 COMPANY SNAPSHOT
16.21.2 SERVICE PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 TAROS CHEMICAL GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 SERVICE PORTFOLIO
16.22.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC TARGET SELECTION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC TARGET VALIDATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC HIT-TO-LEAD IDENTIFICATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC LEAD OPTIMIZATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC CANDIDATE VALIDATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC FRAGMENT-BASED VARIATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC STRUCTURE BASED DRUG DESIGN IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC DIVERSITY ORIENTED SYNTHESIS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC CHEMOGENOMICS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC NATURAL PRODUCTS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC OTHERS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC SMALL MOLECULES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC BIOLOGICS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC ONCOLOGY IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC NEUROLOGY IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC INFECTIOUS AND IMMUNE SYSTEM DISEASES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC CARDIOVASCULAR DISEASES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC DIGESTIVE SYSTEM DISEASES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC OTHERS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATION IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC PHARMACEUTIAL AND BIOTECHNOLOGY COMPANIES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES DISEASES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC OTHERS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 30 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 31 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 32 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 33 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 34 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 35 CHINA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 36 CHINA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 37 CHINA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 38 CHINA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 39 CHINA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 40 JAPAN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 41 JAPAN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 42 JAPAN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 43 JAPAN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 44 JAPAN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 INDIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 46 INDIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 47 INDIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 48 INDIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 49 INDIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 SOUTH KOREA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 51 SOUTH KOREA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 52 SOUTH KOREA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 53 SOUTH KOREA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 54 SOUTH KOREA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 AUSTRALIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 56 AUSTRALIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 57 AUSTRALIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 58 AUSTRALIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 59 AUSTRALIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 60 SINGAPORE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 61 SINGAPORE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 62 SINGAPORE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 63 SINGAPORE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 64 SINGAPORE MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 65 THAILAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 66 THAILAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 67 THAILAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 68 THAILAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 69 THAILAND MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 PHILIPPINES MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 71 PHILIPPINES MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 72 PHILIPPINES MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 73 PHILIPPINES MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 74 PHILIPPINES MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 MALAYSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 76 MALAYSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 77 MALAYSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 78 MALAYSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 79 MALAYSIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 80 INDONESIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 81 INDONESIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 82 INDONESIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 83 INDONESIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 84 INDONESIA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 VIETNAM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 86 VIETNAM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 87 VIETNAM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 88 VIETNAM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 89 VIETNAM MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DROC ANALYSIS
FIGURE 4 MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: END USER COVERAGE GRID
FIGURE 8 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 GROWTH IN BIOLOGICS DISCOVERY AND COLLABORATION AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 PROCESS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
FIGURE 15 ESTIMATED NEW CANCER CASES IN 2021, IN THE U.S.
FIGURE 16 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2021
FIGURE 17 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2020-2029 (USD MILLION)
FIGURE 18 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, CAGR (2022-2029)
FIGURE 19 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, LIFELINE CURVE
FIGURE 20 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2021
FIGURE 21 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 22 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 23 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2021
FIGURE 25 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2020-2029 (USD MILLION)
FIGURE 26 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 27 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 28 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2021
FIGURE 29 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
FIGURE 30 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, CAGR (2022-2029)
FIGURE 31 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, LIFELINE CURVE
FIGURE 32 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2021
FIGURE 33 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 34 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 35 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SNAPSHOT (2021)
FIGURE 37 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021)
FIGURE 38 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 39 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 40 ASIA-PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS (2022-2029)
FIGURE 41 ASIA PACIFIC MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY SHARE 2021 (%)
